Next Article in Journal
Phenotypic Expression of Known and Novel Hemoglobin A2-Variants, Hemoglobin A2-Mae Phrik [Delta 52(D3) Asp > Gly, HBD:c.158A > G], Associated with Hemoglobin E [Beta 26(B8) Glu > Lys, HBB:c.79G > A] in Thailand
Next Article in Special Issue
Cellular Senescence in Normal Mammary Gland and Breast Cancer. Implications for Cancer Therapy
Previous Article in Journal
RNA m6A Modification Changes in Postmortem Nucleus Accumbens of Subjects with Alcohol Use Disorder: A Pilot Study
Previous Article in Special Issue
Potential Refinement of Recurrence Score by pSTAT3 Status
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Genes
Volume 13
Issue 6
10.3390/genes13060960
genes-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

The History of Early Breast Cancer Treatment

by
Judith Ben-Dror
1,
Michal Shalamov
2 and
Amir Sonnenblick
1,2,*
1
Tel Aviv Sourasky Medical Center, Tel Aviv 6423906, Israel
2
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel
*
Author to whom correspondence should be addressed.
Genes 2022, 13(6), 960; https://doi.org/10.3390/genes13060960
Submission received: 1 May 2022 / Revised: 22 May 2022 / Accepted: 23 May 2022 / Published: 27 May 2022
(This article belongs to the Special Issue Molecular Therapeutics of Breast Cancer)
Browse Figures
Review Reports Versions Notes

Abstract

“The story of cancer is the story of human ingenuity, resilience, and perseverance, but also of hubris, paternalism, and misperception” (Siddhartha Mukherjee). The present review discusses the evolution of early breast cancer (BC) treatment philosophy in the last 50 years and the shift from an emphasis on local therapy to an emphasis on systemic precision treatment options.
Keywords: breast cancer; molecular therapeutics; systemic treatment; targeted therapies breast cancer; molecular therapeutics; systemic treatment; targeted therapies

Share and Cite

MDPI and ACS Style

Ben-Dror, J.; Shalamov, M.; Sonnenblick, A. The History of Early Breast Cancer Treatment. Genes 2022, 13, 960. https://doi.org/10.3390/genes13060960

AMA Style

Ben-Dror J, Shalamov M, Sonnenblick A. The History of Early Breast Cancer Treatment. Genes. 2022; 13(6):960. https://doi.org/10.3390/genes13060960

Chicago/Turabian Style

Ben-Dror, Judith, Michal Shalamov, and Amir Sonnenblick. 2022. "The History of Early Breast Cancer Treatment" Genes 13, no. 6: 960. https://doi.org/10.3390/genes13060960

APA Style

Ben-Dror, J., Shalamov, M., & Sonnenblick, A. (2022). The History of Early Breast Cancer Treatment. Genes, 13(6), 960. https://doi.org/10.3390/genes13060960

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop